Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abraxis to buy Pfizer manufacturing plant
This 56-acre site consists of a 172,000 square foot validated manufacturing plant with capabilities of producing EU and US compliant injectable pharmaceuticals, as well as protein-based biologics and
This 56-acre site consists of a 172,000 square foot validated manufacturing plant with capabilities of producing EU and US compliant injectable pharmaceuticals, as well as protein-based biologics and
Patients with clinical stage IV or inoperable stage III breast cancer are expected to be enrolled in the study. The purpose of the study will be to evaluate
Picoplatin is a new generation platinum therapy that provides a differentiated spectrum of activity, reduced reactivity and an improved safety profile. An intravenous chemotherapeutic agent, picoplatin is designed
This conclusion was drawn from an analysis of a randomized placebo-controlled clinical trial covering 13 years. The selenium-cardiovascular disease (CVD) association was a secondary endpoint in the Nutritional
In the global medicinal chemistry agreement a dedicated team of chemists from Evotec supports all of Roche’s European and US research sites in the design and synthesis of
Under the deal, Millipore will assume the Serologicals’ debt and pay its shareholders $31.55 in cash for each share they own. According to Millipore, the combined company will
In this new project, bavituximab, formally Tarvacin, will be labeled with radioactive isotopes to assess its potential as an imaging agent to identify tumor metastases and as a
An initial phase I study on AT9283 in hematological cancers will be conducted at a leading oncology center in the US, and the company plans to initiate additional
In the trial the drug was specifically evaluated in the treatment of high-grade cervical intraepithelial neoplasia (CIN), an intermediate disorder which results from the common sexually transmitted disease
Sparlon is a new formulation and dosage strength of modafinil, the active ingredient in Provigil the company’s already approved treatment for a number of sleep disorders. The company